Related references
Note: Only part of the references are listed.IL-33 in COPD: the hunt for responder subgroups
Dave Singh
LANCET RESPIRATORY MEDICINE (2022)
Assessment of variability in the plasma 7k SomaScan proteomics assay
Julian Candia et al.
SCIENTIFIC REPORTS (2022)
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie Zheng et al.
NATURE GENETICS (2020)
Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants
Xutong Zhao et al.
NATURE COMMUNICATIONS (2020)
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations
Phuwanat Sakornsakolpat et al.
NATURE GENETICS (2019)
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries
Nick Shrine et al.
NATURE GENETICS (2019)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease Reply
Robert A. Stockley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function
Annah B. Wyss et al.
NATURE COMMUNICATIONS (2018)
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Peter J. Barnes
NATURE REVIEWS IMMUNOLOGY (2018)
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis
Brian D. Hobbs et al.
NATURE GENETICS (2017)
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets
Louise V. Wain et al.
NATURE GENETICS (2017)
Interleukin 33 exacerbates antigen driven airway hyperresponsiveness, inflammation and remodeling in a mouse model of asthma
L. C. Sjoberg et al.
SCIENTIFIC REPORTS (2017)
Assessment of Variability in the SOMAscan Assay
Julian Candia et al.
SCIENTIFIC REPORTS (2017)
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease
Debby Ngo et al.
CIRCULATION (2016)
Protective Role of Kallistatin in Vascular and Organ Injury
Julie Chao et al.
HYPERTENSION (2016)
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
Peter Ganz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effects of Long-Term Storage Time and Original Sampling Month on Biobank Plasma Protein Concentrations
Stefan Enroth et al.
EBIOMEDICINE (2016)
Transforming Growth Factor-β Superfamily in Obstructive Lung Diseases
Fien M. Verhamme et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein
Eleanor G. Healey et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein
Eleanor G. Healey et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Martina Sattlecker et al.
ALZHEIMERS & DEMENTIA (2014)
Recombinant Human Kallistatin Inhibits Angiogenesis by Blocking VEGF Signaling Pathway
K. F. Huang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis
Michael H. Cho et al.
LANCET RESPIRATORY MEDICINE (2014)
TWEAK/Fn14 signaling axis mediates skeletal muscle atrophy and metabolic dysfunction
Shuichi Sato et al.
FRONTIERS IN IMMUNOLOGY (2014)
Validation of a blood protein signature for non-small cell lung cancer
Michael R. Mehan et al.
CLINICAL PROTEOMICS (2014)
Heritability of Chronic Obstructive Pulmonary Disease and Related Phenotypes in Smokers
Jin J. Zhou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The ConsensusPathDB interaction database: 2013 update
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2013)
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
Annelyse Duvoix et al.
THORAX (2013)
Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology
Marie-Christine Bouton et al.
BLOOD (2012)
Association between C-reactive Protein Concentration and Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis
Y. Zhang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Advances in human proteomics at high scale with the SOMAscan proteomics platform
Larry Gold et al.
NEW BIOTECHNOLOGY (2012)
Genome-Wide Association Studies of Asthma in Population-Based Cohorts Confirm Known and Suggested Loci and Identify an Additional Association near HLA
Adaikalavan Ramasamy et al.
PLOS ONE (2012)
Can spirometric norms be set using pre- or post- bronchodilator test results in older people?
Bernet Kato et al.
RESPIRATORY RESEARCH (2012)
Epidemiology of chronic obstructive pulmonary disease: a literature review
Catherine E. Rycroft et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Consensus-Phenotype Integration of Transcriptomic and Metabolomic Data Implies a Role for Metabolism in the Chemosensitivity of Tumour Cells
Rachel Cavill et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
David M. Mannino et al.
RESPIRATORY RESEARCH (2011)
Impact of the storage temperature on human plasma proteomic analysis: Implications for the use of human plasma collections in research
Maria Insenser et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function
Olga V. Moroz et al.
BMC BIOCHEMISTRY (2009)
MMP12, Lung Function, and COPD in High-Risk Populations
Gary M. Hunninghake et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease
Yuji Higashimoto et al.
RESPIRATORY MEDICINE (2009)
Inflammatory markers and longitudinal lung function decline in the elderly
Rui Jiang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Bone morphogenetic protein-9 is a circulating vascular quiescence factor
Laurent David et al.
CIRCULATION RESEARCH (2008)
Mast cell and monocyte recruitment by S100A12 and its hinge domain
Wei Xing Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism
Kerry B. Goralski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs
Andrew Churg et al.
THORAX (2007)
Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis
Dirk Foell et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
The SERPINE2 gene is associated with chronic obstructive pulmonary disease
DL DeMeo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Y Higashimoto et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Role of tissue factor in hemostasis, thrombosis, and vascular development
N Mackman
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Proinflammatory activities of S100: Proteins S10OA8, S10OA9, and S100A8/A9 induce neutrophil chemotaxis and adhesion
C Ryckman et al.
JOURNAL OF IMMUNOLOGY (2003)
Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2
RS Koduri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tissue factor as a proinflammatory agent
MI Bokarewa et al.
ARTHRITIS RESEARCH (2002)
Share Paper
